San Diego Doctor Pleads Guilty to Distributing Ketamine that Led to Matthew Perry’s Death October 3, 2024
NRx Pharmaceuticals Completes 12 Months of Stability on First Commercial-Scale Lot of IV Ketamine September 30, 2024
Johnson & Johnson Seeks FDA Approval of Spravato as Monotherapy for Adults with Treatment-Resistant Depression July 24, 2024